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Abstract
Several  biomarkers are used in confirming the diagnosis of  cognitive disorders.  This study
evaluates  whether  the  level  of  these  markers  after  heart  surgery  correlates  with  the
development of cognitive dysfunction, which is a frequent complication of cardiac interventions.
Concentrations of amyloid-β peptide, tau, and S100β in the cerebro-spinal fluid were assessed,
as well as cognitive functions were evaluated before and after coronary artery bypass grafting,
utilizing immuno-assays and psychometric tests,  respectively.  A drastic rise in the level  of
S100β was observed one week after the surgery, a mark of a severe generalized cerebral injury.
The  level  of  amyloid-β  peptide  significantly  decreased,  whereas  the  concentration  of  tau
markedly increased six months postoperatively. Gradual cognitive decline was also present.
These findings clearly demonstrate post-surgical cognitive impairment associated with changes
in biomarkers similar to that seen in Alzheimer's disease, suggesting a unifying pathognomic
factor  between  the  two  disorders.  A  holistic  approach  to  coronary  heart  disease  and
Alzheimer's-type dementia is proposed. © 2010 IOS Press and the authors. All rights reserved.
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